TY - JOUR T1 - Right Anterior Temporal Degeneration, Emotions, and Loss of Nonverbal Semantics: Guidelines for Diagnosis of the Emotional Semantic Variant Frontotemporal Dementia JF - medRxiv DO - 10.1101/2021.06.07.21258432 SP - 2021.06.07.21258432 AU - Kyan Younes AU - Valentina Borghesani AU - Maxime Montembeault AU - Salvatore Spina AU - Maria Luisa Mandelli AU - Ariane E. Welch AU - Elizabeth Weis AU - Patrick Callahan AU - Fanny M. Elahi AU - Alice Y. Hua AU - David C. Perry AU - Anna Karydas AU - Daniel Geschwind AU - Eric Huang AU - Lea T. Grinberg AU - Joel H. Kramer AU - Adam L. Boxer AU - Gil D. Rabinovici AU - Howard J. Rosen AU - William W. Seeley AU - Zachary A. Miller AU - Bruce L. Miller AU - Virginia E. Sturm AU - Katherine P. Rankin AU - Maria Luisa Gorno-Tempini Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/06/10/2021.06.07.21258432.abstract N2 - Anterior temporal lobe (ATL) degeneration is caused by a pathological process that has a focal onset in the left or right hemisphere. Patients with left-lateralized ATL atrophy typically meet criteria for semantic variant primary progressive aphasia (PPA), a clinical syndrome characterized by loss of verbal semantic knowledge. There is less consensus regarding the symptoms that emerge when atrophy targets the right ATL (rATL), but previous studies have emphasized prosopagnosia as well as alterations in emotion, memory, behavior, and semantic knowledge, symptoms that often lead to a diagnosis of behavioral variant frontotemporal dementia (bvFTD). The goal of the present study was to characterize the cognitive and socioemotional deficits of patients with rATL degeneration in order to refine current conceptualizations of the rATL clinical syndrome.We identified individuals clinically diagnosed as bvFTD or PPA in our cohort of patients prospectively evaluated for FTD-spectrum disorders. We selected patients who also underwent structural MRI and a comprehensive, multidisciplinary evaluation (n = 478). Based on structural MRI atrophy index, individuals with predominant, rATL atrophy (n = 46) were identified and patients with co-occurrence of significant frontal atrophy were excluded. Nineteen patients with rATL degeneration had undergone autopsy. We used the clinical histories to identify early symptoms and examined the cognitive, socioemotional, genetic, and pathological profiles of patients with rATL degeneration.In patients with rATL degeneration, the most common early clinical symptoms were loss of empathy (27%), person-specific semantic knowledge (23%), and complex compulsions (18%). On socioemotional testing and informant-reported measures, patients exhibited diminished interpersonal warmth, empathy, and emotional theory of mind. Neuropsychological testing revealed deficits in identifying famous people and discriminating facial affect despite preserved face perception. FTLD-TDP was the most frequent pathological correlate of rATL degeneration (84%), followed by Pick’s type (10%), a subtype of FTLD-tau.Our results indicate that patients with early, rATL-predominant degeneration present with a behavioral syndrome that results from loss of empathy for others. The underlying mechanism is a progressive loss of semantic knowledge for concepts of social-emotional relevance. We herein refer to this syndrome as “emotional semantic variant frontotemporal dementia.” We propose novel diagnostic criteria for this rATL syndrome in order to facilitate early identification in clinical and research settings. This classification is relevant because, if appropriately diagnosed, these patients most often have FTLD-TDP Type-C pathology.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was funded by the National Institutes of Health (NINDS R01NS050915, NIDCD K24DC015544, NIDCD R03DC013403, NIDCD F32DC009145, NIA U01AG052943, NIA P50AG023501, NIA P01AG019724, NIA R01AG038791, NINDS U54NS092089, NIA K08AG052648, NIA R01AG029577, NIA K23-AG021606, NIA P50AG023501), Alzheimer Disease Research Center of California (03- 75271 DHS/ADP/ARCC); Larry L. Hillblom Foundation; John Douglas French Alzheimer Foundation; Koret Family Foundation; Consortium for Frontotemporal Dementia Research; and McBean Family Foundation. LTG is partially funded by NIH K24AG053435. These supporting sources were not involved in the study design, collection, analysis or interpretation of data, nor were they involved in writing the paper or in the decision to submit this report for publication.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:University of California San Francisco Human Research Protection Program.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data for this study is available upon request.bvFTDBehavioral variant frontotemporal dementiaesvFTDEmotional semantic variant frontotemporal dementiaFTDFrontotemporal dementiaFTLDFrontotemporal lobar degenerationrATLright anterior temporal lobeSDSemantic dementiasvPPASemantic variant primary progressive aphasiaTDP-43transactive response DNA binding protein 43 ER -